| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-DIST | DEUDA PRIVADA EMERGENTES HRD CCY | 796,909335 | 14/10/2026 | 3,21% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 147,199643 | 14/10/2026 | 2,70% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-DIST | DEUDA PRIVADA EMERGENTES HRD CCY | 826,681554 | 14/10/2026 | 2,70% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND P-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 137,204109 | 14/10/2026 | 2,29% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND Q-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 117,204109 | 14/10/2026 | 2,62% | · | ND |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC | RVI BIOTECNOLOGÍA | 927,248394 | 15/10/2026 | 22,77% | 52,30% | *** |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) Q-ACC | RVI BIOTECNOLOGÍA | 421,038544 | 15/10/2026 | 23,77% | 57,04% | *** |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) QL-ACC | RVI BIOTECNOLOGÍA | 137,553533 | 15/10/2026 | 23,96% | 58,00% | *** |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) P-ACC | RVI CHINA | 73,610000 | 15/10/2026 | -17,51% | 1,62% | * |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) Q-ACC | RVI CHINA | 60,270000 | 15/10/2026 | -16,75% | 4,93% | ** |
